Man Group’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Man Group’s Portfolio PTLA Stock Details PTLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-447,963	Closed	-$8.06M	–	1941
2020 Q2	$8.06M	Buy	447,963 +376,733	+529%	+$5.24M	0.04%	446
2020 Q1	$508K	Buy	+71,230	New	+$889K	﹤0.01%	1276
2019 Q3	–	Sell	-52,653	Closed	-$1.43M	–	2003
2019 Q2	$1.43M	Sell	52,653 -51,537	-49%	-$1.62M	0.01%	1422
2019 Q1	$3.62M	Buy	104,190 +64,654	+164%	+$1.87M	0.01%	1079
2018 Q4	$772K	Buy	39,536 +18,645	+89%	+$383K	﹤0.01%	1531
2018 Q3	$556K	Sell	20,891 -64,477	-76%	-$2.11M	﹤0.01%	1815
2018 Q2	$3.22M	Buy	+85,368	New	+$3.27M	0.01%	1157

Man Group's PTLA Position: Q3 2020 in Review

Man Group sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q3 2020, closing a stake of 447,963 shares — an estimated $8.06M sold.

Man Group first reported a position in PTLA in Q2 2018 and held it in 7 quarters. The position peaked at $8.06M in Q2 2020. 0 funds tracked by Wall St. Rank hold PTLA as of Q3 2020.

Man Group reported no remaining Portola Pharmaceuticals, Inc. position as of Q3 2020 after selling out during the quarter.
Man Group sold 447,963 Portola Pharmaceuticals, Inc. shares in Q3 2020, an estimated $8.06M.
Man Group first reported a position in Portola Pharmaceuticals, Inc. in Q2 2018 and held it in 7 quarters.
Man Group's Portola Pharmaceuticals, Inc. position peaked at $8.06M in Q2 2020.
0 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q3 2020.

Based on Man Group's 13F filing for Q3 2020, filed 16 Nov 2020.